NCT03012763View on ClinicalTrials.gov

Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

January 31, 2017

Conditions
PharmacokineticsMagnetic Resonance ImagingAdministration, Oral
Interventions
DRUG

Paracetamol

Oral administration of 250 mg paracetamol

DRUG

Sulfasalazine

Oral administration of 50 mg sulfasalazine

DRUG

Fexofenadine

Oral administration of 120 mg fexofenadine

DRUG

Valsartan

Oral administration of 40 mg valsartan

DEVICE

non-caloric water

Oral administration of 240 ml non-caloric water

DEVICE

caloric drink

Oral administration of 240 ml caloric drink

DEVICE

grapefruit juice

Oral administration of 240 ml grapefruit juice

All Listed Sponsors
lead

University Medicine Greifswald

OTHER

NCT03012763 - Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums | Biotech Hunter | Biotech Hunter